| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 3, 145-151, Copyright © 1989 by The Federation of American Societies for Experimental Biology
REVIEWS |
EG Erdos and RA Skidgel
Department of Anesthesiology, College of Medicine, University of Illinois, Chicago 60612.
This report summarizes the recent rapid development of research on neutral endopeptidase 24.11 (enkephalinase; NEP) and on two other metalloenzymes, meprin and endopeptidase 24.15. NEP cleaves a variety of active peptides, including enkephalins, at the amino side of hydrophobic amino acids. The cDNA for human, rat, and rabbit NEP has been cloned and the deduced protein sequences revealed a high degree of homology (93-94%). Site-directed mutagenesis proved that an active site glutamic acid is involved in catalysis and two active site histidines are responsible for binding the zinc cofactor. Although NEP was originally discovered in the kidney, it is widely distributed in the body including specific structures in the central nervous system, lung, male genital tract, and intestine and in neutrophils, fibroblasts, and epithelial cells. In tissues and cells NEP is bound to plasma membrane through a hydrophobic membrane-spanning domain near the NH2 terminus, but it is present in soluble form in urine and blood. In addition to enkephalins, NEP cleaves kinins, chemotactic peptide, atrial natriuretic factor (ANF), and substance P in vivo. NEP in the lung is a major inactivator of substance P, which constricts the airway smooth muscles. Because of the possible involvement of NEP in the metabolism of opioid peptides and the cardiac hormone ANF, orally active inhibitors have been synthesized. Compounds that inhibit both aminopeptidase and NEP were reported to prolong the analgesic effects of enkephalins. Other inhibitors given per os prolonged the renal effects of exogenous ANF. A newly synthesized specific inhibitor of NEP was also active in animal experiments as an analgesic. Studies on the structure and function of NEP should lead to further development of therapeutically applicable inhibitors.
This article has been cited by other articles:
|
|
 |
|
  Y. Takeuchi, K. Uetsuka, M. Murayama, F. Kikuta, A. Takashima, K. Doi, and H. Nakayama Complementary Distributions of Amyloid-{beta} and Neprilysin in the Brains of Dogs and Cats Vet. Pathol., July 1, 2008; 45(4): 455 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nowicki, D. Ostalska-Nowicka, B. Kondraciuk, and B. Miskowiak The significance of substance P in physiological and malignant haematopoiesis J. Clin. Pathol., July 1, 2007; 60(7): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Orr, D. P. Wilson, J. M. Taylor, P. G. Bannon, C. Geczy, M. P. Davenport, and L. Kritharides A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1707 - R1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Medja, V. Lelievre, R. H. Fontaine, F. Lebas, P. Leroux, T. Ouimet, A. Saria, C. Rougeot, P. Dournaud, and P. Gressens Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice Brain, December 1, 2006; 129(12): 3209 - 3223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Barber, M. Kanagasundaram, C. R. Anderson, L. M. Burrell, and R. L. Woods Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia Cardiovasc Res, July 1, 2006; 71(1): 179 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sansoe, M. Aragno, R. Mastrocola, J. C. Cutrin, S. Silvano, G. Mengozzi, A. Smedile, F. Rosina, O. Danni, and M. Rizzetto Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1337 - F1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. H. Christoffersen, M. Aplin, C. C. Strom, S. P. Sheikh, O. Skott, P. K. Busk, S. Haunso, and L. B. Nielsen Increased natriuretic peptide receptor A and C gene expression in rats with pressure-overload cardiac hypertrophy Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1635 - H1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kajiyama, K. Shibata, M. Terauchi, T. Morita, K. Ino, S. Mizutani, and F. Kikkawa Neutral Endopeptidase 24.11/CD10 Suppresses Progressive Potential in Ovarian Carcinoma In vitro and In vivo Clin. Cancer Res., March 1, 2005; 11(5): 1798 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pfister, N. E. Martin, L. P. Haskell, and J. S. Barrett Optimizing Dose Selection with Modeling and Simulation: Application to the Vasopeptidase Inhibitor M100240 J. Clin. Pharmacol., June 1, 2004; 44(6): 621 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.T. Lundy and G.J. Linden NEUROPEPTIDES AND NEUROGENIC MECHANISMS IN ORAL AND PERIODONTAL INFLAMMATION Crit. Rev. Oral. Biol. Med., March 1, 2004; 15(2): 82 - 98. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Ebihara, G. Seno Di Marco, M. Aparecida Juliano, and D. E. Casarini Neutral endopeptidase expression in mesangial cells Journal of Renin-Angiotensin-Aldosterone System, December 1, 2003; 4(4): 228 - 233. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Debiec, V. Guigonis, B. Mougenot, J.-P. Haymann, A. Bensman, G. Deschenes, and P. M. Ronco Antenatal Membranous Glomerulonephritis with Vascular Injury Induced by Anti-Neutral Endopeptidase Antibodies: Toward New Concepts in the Pathogenesis of Glomerular Diseases J. Am. Soc. Nephrol., June 1, 2003; 14(90001): S27 - 32. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Campbell Vasopeptidase Inhibition: A Double-Edged Sword? Hypertension, March 1, 2003; 41(3): 383 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T-L Wang and C-R Hung Enhanced endothelin-1 degradation by intravenous morphine in patients with congestive heart failure: role of neutral endopeptidase 24.11 Heart, February 1, 2003; 89(2): 211 - 212. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schling and T. Schafer Human Adipose Tissue Cells Keep Tight Control on the Angiotensin II Levels in Their Vicinity J. Biol. Chem., December 6, 2002; 277(50): 48066 - 48075. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cataliotti, M. Giordano, E. De Pascale, G. Giordano, P. Castellino, M. Jougasaki, L. C. Costello, G. Boerrigter, T. Tsuruda, P. Belluardo, et al. CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome Am J Physiol Renal Physiol, September 1, 2002; 283(3): F464 - F472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Ma, H.-S. Huang, M.-S. Wu, C.-T. Chien, and C.-F. Chen Impaired Renal Sensory Responses after Renal Ischemia in the Rat J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1872 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Debiec, V. Guigonis, B. Mougenot, F. Decobert, J.-P. Haymann, A. Bensman, G. Deschenes, and P. M. Ronco Antenatal Membranous Glomerulonephritis Due to Anti-Neutral Endopeptidase Antibodies N. Engl. J. Med., June 27, 2002; 346(26): 2053 - 2060. [Full Text] [PDF]
|
|
|
|
|
|
G. A Sagnella Review: Vasopeptidase inhibitors Journal of Renin-Angiotensin-Aldosterone System, June 1, 2002; 3(2): 90 - 95. [Abstract] [PDF]
|
|
|
|
|
|
M.-C. Ma, H.-S. Huang, and C.-F. Chen Impaired Renal Sensory Responses after Unilateral Ureteral Obstruction in the Rat J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1008 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Deddish, B. M. Marcic, F. Tan, H. L. Jackman, Z. Chen, and E. G. Erdos Neprilysin Inhibitors Potentiate Effects of Bradykinin on B2 Receptor Hypertension, February 1, 2002; 39(2): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fielitz, A. Dendorfer, R. Pregla, E. Ehler, H. R. Zurbrugg, J. Bartunek, R. Hetzer, and V. Regitz-Zagrosek Neutral Endopeptidase Is Activated in Cardiomyocytes in Human Aortic Valve Stenosis and Heart Failure Circulation, January 22, 2002; 105(3): 286 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. QUASCHNING, L. V. D'USCIO, S. SHAW, H.-J. GRONE, F. RUSCHITZKA, and T. F. LUSCHER Vasopeptidase Inhibition Restores Renovascular Endothelial Dysfunction in Salt-Induced Hypertension J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2280 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Oliveri, M. P. Ocaranza, X. Campos, S. Lavandero, and J. E. Jalil Angiotensin I-Converting Enzyme Modulates Neutral Endopeptidase Activity in the Rat Hypertension, September 1, 2001; 38(3): 650 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Sagnella Atrial natriuretic peptide mimetics and vasopeptidase inhibitors Cardiovasc Res, August 15, 2001; 51(3): 416 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Quaschning, L. V. d'Uscio, S. Shaw, H. Viswambharan, F. T. Ruschitzka, and T. F. Luscher Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1176 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Quaschning, L. V. d'Uscio, S. Shaw, and T. F. Luscher Vasopeptidase Inhibition Exhibits Endothelial Protection in Salt-Induced Hypertension Hypertension, April 1, 2001; 37(4): 1108 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Oetjen, P. Fives-Taylor, and E. Froeliger Characterization of a Streptococcal Endopeptidase with Homology to Human Endothelin-Converting Enzyme Infect. Immun., January 1, 2001; 69(1): 58 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, T. Quaschning, J. C. Burnett Jr, and T. F. Luscher Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition Hypertension, January 1, 2001; 37(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A Sagnella Practical implications of current natriuretic peptide research Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 304 - 315. [PDF]
|
|
|
|
|
|
Y. Matsumura, T. Kuro, Y. Kobayashi, F. Konishi, M. Takaoka, J. L. Wessale, T. J. Opgenorth, C. E. Gariepy, and M. Yanagisawa Exaggerated Vascular and Renal Pathology in Endothelin-B Receptor-Deficient Rats With Deoxycorticosterone Acetate-Salt Hypertension Circulation, November 28, 2000; 102(22): 2765 - 2773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Troughton, M. T. Rademaker, J. D. Powell, T. G. Yandle, E. A. Espiner, C. M. Frampton, M. G. Nicholls, and A. M. Richards Beneficial Renal and Hemodynamic Effects of Omapatrilat in Mild and Severe Heart Failure Hypertension, October 1, 2000; 36(4): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Smith, R. A. Lew, C. N. Shrimpton, R. G. Evans, and G. Abbenante A Novel Stable Inhibitor of Endopeptidases EC 3.4.24.15 and 3.4.24.16 Potentiates Bradykinin-Induced Hypotension Hypertension, February 1, 2000; 35(2): 626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Kumar, Y. R. Kou, J. L. Overholt, and N. R. Prabhakar Involvement of substance P in neutral endopeptidase modulation of carotid body sensory responses to hypoxia J Appl Physiol, January 1, 2000; 88(1): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Johnson, T. Stevenson, and K. Ahn Hydrolysis of Peptide Hormones by Endothelin-converting Enzyme-1. A COMPARISON WITH NEPRILYSIN J. Biol. Chem., February 12, 1999; 274(7): 4053 - 4058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, F. A. Recchia, R. Bernstein, X. Xu, A. Nasjletti, and T. H. Hintze Kinin-Mediated Coronary Nitric Oxide Production Contributes to the Therapeutic Action of Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors and Amlodipine in the Treatment in Heart Failure J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 742 - 751. [Abstract] [Full Text]
|
|
|
|
|
|
T. Tikkanen, I. Tikkanen, M. D. Rockell, T. J. Allen, C. I. Johnston, M. E. Cooper, and L. M. Burrell Dual Inhibition of Neutral Endopeptidase and Angiotensin-Converting Enzyme in Rats With Hypertension and Diabetes Mellitus Hypertension, October 1, 1998; 32(4): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Ferro, J. C. Spratt, W. G. Haynes, and D. J. Webb Inhibition of Neutral Endopeptidase Causes Vasoconstriction of Human Resistance Vessels In Vivo Circulation, June 16, 1998; 97(23): 2323 - 2330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-J. Dumoulin, A. Adam, C. Blais Jr., and D. Lamontagne Metabolism of bradykinin by the rat coronary vascular bed Cardiovasc Res, April 1, 1998; 38(1): 229 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Croxatto, R. Silva, X. Figueroa, R. Albertini, J. Roblero, and M. P. Boric A Peptide Released by Pepsin From Kininogen Domain 1 Is a Potent Blocker of ANP-Mediated Diuresis-Natriuresis in the Rat Hypertension, October 1, 1997; 30(4): 897 - 904. [Abstract] [Full Text]
|
|
|
|
|
|
D. A. Bagarozzi Jr., R. Pike, J. Potempa, and J. Travis Purification and Characterization of a Novel Endopeptidase in Ragweed (Ambrosia artemisiifolia) Pollen J. Biol. Chem., October 18, 1996; 271(42): 26227 - 26232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kugiyama, S. Sugiyama, T. Matsumura, Y. Ohta, H. Doi, and H. Yasue Suppression of Atherosclerotic Changes in Cholesterol-Fed Rabbits Treated With an Oral Inhibitor of Neutral Endopeptidase 24.11 (EC 3.4.24.11) Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 1080 - 1087. [Abstract] [Full Text]
|
|
|
|
|
|
R. Willenbrock, M. Scheuermann, K. Hohnel, F. C. Luft, and R. Dietz Acute and Chronic Neutral Endopeptidase Inhibition in Rats With Aortocaval Shunt Hypertension, June 1, 1996; 27(6): 1259 - 1266. [Abstract] [Full Text]
|
|
|
|
|
|
S.-i. Ando, M. A. Rahman, G. C. Butler, B. L. Senn, and J. S. Floras Comparison of Candoxatril and Atrial Natriuretic Factor in Healthy Men : Effects on Hemodynamics, Sympathetic Activity, Heart Rate Variability, and Endothelin Hypertension, December 1, 1995; 26(6): 1160 - 1166. [Abstract] [Full Text]
|
|
|
|
|
|
M. P. Boric and H. R. Croxatto Inhibition of Atrial Natriuretic Peptide Excretory Action by Bradykinin Hypertension, December 1, 1995; 26(6): 1167 - 1172. [Abstract] [Full Text]
|
|
|
|
|
|
K. Graf, P. Koehne, M. Grafe, M. Zhang, W. Auch-Schwelk, and E. Fleck Regulation and Differential Expression of Neutral Endopeptidase 24.11 in Human Endothelial Cells Hypertension, August 1, 1995; 26(2): 230 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
K. B. Margulies, P. L. Barclay, and J. C. Burnett Jr The Role of Neutral Endopeptidase in Dogs With Evolving Congestive Heart Failure Circulation, April 1, 1995; 91(7): 2036 - 2042. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Motwani, C. C. Lang, G. Cramb, and A. D. Struthers Natriuretic Response to Neutral Endopeptidase Inhibition Is Blunted by Enalapril in Healthy Men Hypertension, April 1, 1995; 25(4): 637 - 642. [Abstract] [Full Text]
|
|
|
|
 |
|
 M Weil, A Itin, and E Keshet A role for mesenchyme-derived tachykinins in tooth and mammary gland morphogenesis Development, January 8, 1995; 121(8): 2419 - 2428. [Abstract] [PDF]
|
|
|
|
|
|
B Spencer-Dene, P Thorogood, S Nair, A. Kenny, M Harris, and B Henderson Distribution of, and a putative role for, the cell-surface neutral metallo-endopeptidases during mammalian craniofacial development Development, January 11, 1994; 120(11): 3213 - 3226. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
